PortfoliosLab logo

Arcturus Therapeutics Holdings Inc. (ARCT)

Equity · Currency in USD · Last updated Aug 13, 2022

Company Info

ISINUS03969T1097
CUSIP03969T109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$19.18
Year Range$12.26 - $57.22
EMA (50)$18.16
EMA (200)$26.29
Average Volume$614.28K
Market Capitalization$509.74M

ARCTShare Price Chart


Chart placeholderClick Calculate to get results

ARCTPerformance

The chart shows the growth of $10,000 invested in Arcturus Therapeutics Holdings Inc. in May 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,629 for a total return of roughly -63.71%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%MarchAprilMayJuneJulyAugust
-21.62%
-4.36%
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)

ARCTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M4.81%12.08%
6M-24.19%-4.97%
YTD-48.18%-10.20%
1Y-59.00%-3.65%
5Y21.40%11.89%
10Y-10.41%10.86%

ARCTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-29.40%-8.27%12.47%-28.12%2.58%-20.82%11.50%9.29%
202167.04%-27.31%-21.59%-11.23%-20.29%15.81%-7.48%75.06%-12.83%-5.92%-11.57%-6.89%
2020-5.24%34.47%-1.88%153.86%12.87%20.03%11.75%-7.64%-11.07%26.06%69.67%-52.72%
201910.38%0.80%35.52%11.13%-8.04%35.24%44.17%-17.49%-8.55%7.69%0.99%-2.69%
2018-2.39%-27.84%-1.79%-6.73%15.40%43.24%-5.90%1.50%9.14%-38.80%15.53%-27.52%
2017-50.00%24.76%-12.98%0.88%-3.48%0.90%-0.89%-7.21%-1.94%55.45%-19.75%-9.86%
2016-18.47%-8.98%-18.67%5.80%32.67%-15.60%-4.68%14.95%-49.80%-22.27%-0.52%9.95%
201565.42%22.04%-25.23%4.44%30.95%-15.06%13.00%3.92%-21.35%37.91%-20.89%-4.70%
201421.67%8.72%-23.77%-4.79%-0.98%1.17%0.64%10.56%-19.83%-76.55%2.21%0.81%
2013-4.64%-4.86%51.09%24.54%39.95%-9.42%6.98%2.97%

ARCTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arcturus Therapeutics Holdings Inc. Sharpe ratio is -0.60. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.60
-0.20
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)

ARCTDividend History


Arcturus Therapeutics Holdings Inc. doesn't pay dividends

ARCTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-89.26%
-10.77%
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)

ARCTWorst Drawdowns

The table below shows the maximum drawdowns of the Arcturus Therapeutics Holdings Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arcturus Therapeutics Holdings Inc. is 97.70%, recorded on Dec 28, 2018. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.7%Oct 8, 20131316Dec 28, 2018
-14.65%Aug 6, 201321Sep 4, 20134Sep 10, 201325
-12.05%May 23, 201322Jun 24, 20139Jul 8, 201331
-7.48%Jul 15, 20134Jul 18, 201310Aug 1, 201314
-7.2%Sep 16, 20137Sep 24, 20132Sep 26, 20139
-3.58%Sep 30, 20131Sep 30, 20132Oct 2, 20133

ARCTVolatility Chart

Current Arcturus Therapeutics Holdings Inc. volatility is 136.43%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MarchAprilMayJuneJulyAugust
136.43%
16.68%
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)